8-K

CRH PUBLIC LTD CO 8-K Report (May 10, 2013)

Filed May 10, 2013For Securities:CRH

Summary

This Form 6-K filing from CRH Public Limited Company (CRH) on May 8, 2013, primarily serves to disclose a change in director's details in compliance with Listing Rules. Specifically, it announces that Ms. Heather Ann McSharry was appointed as a non-executive director of Jazz Pharmaceuticals plc on May 7, 2013. While this filing does not contain financial performance data or strategic operational updates, it is important for investors to note any changes in the directorship of public companies, as these can sometimes be precursors to broader strategic shifts or indicate governance activity.

Key Highlights

  • 1CRH Public Limited Company filed a Form 6-K on May 8, 2013.
  • 2The filing is a Report of Foreign Private Issuer.
  • 3The primary purpose of the filing is to notify of a change in a director's details.
  • 4Ms. Heather Ann McSharry was appointed as a non-executive director of Jazz Pharmaceuticals plc.
  • 5The appointment date for Ms. McSharry at Jazz Pharmaceuticals plc was May 7, 2013.
  • 6This disclosure is made to comply with paragraph 9.6.14 of the Listing Rules.
  • 7The filing does not contain financial results or operational updates for CRH.

Frequently Asked Questions

This filing is a Form 6-K, which is a Report of Foreign Private Issuer. Its main purpose is to notify the SEC and investors about a change in director's details, specifically that Ms. Heather Ann McSharry was appointed as a non-executive director of Jazz Pharmaceuticals plc.

No, this filing does not contain any financial performance data, earnings reports, or operational updates for CRH. It is solely a disclosure of a director's outside appointment.

The filing states that this disclosure is made to comply with paragraph 9.6.14 of the Listing Rules. These rules often require public companies to disclose significant appointments of their directors to other public companies to ensure transparency and inform stakeholders about potential conflicts of interest or governance structures.

The filing does not state that Ms. McSharry is leaving her role at CRH. It only announces her appointment as a non-executive director at Jazz Pharmaceuticals plc.